With Moderna’s vaccine reporting an efficacy rate of 94.5% and the Dow hitting an all-time high of 30,000, is it time to change your investment plan?

The Morning Run also gets into US Treasuries, how RCEP will impact the US, and whether increased regulatory scrutiny in China is a concern for investors.

Produced by: Mike Gong

Presented by: Lyn Mak, Noelle Lim, Roshan Kanesan

Download the BFM mobile app. Stay at home and stay up-to-date.

Tags:  stocks,  rotational plays,  vaccine,  moderna,  dow jones,  rcep,  biden,  alibaba,  ant group,  community party,  Financial Services,  Government/Regulatory/Policy Making,  Healthcare, Pharma, Biotech,  Internet, e-Business, e-commerce,  Telecom, IT, Technology,  Economy, Markets,  Politics, News, Current Affairs,  Health,  Personal Finance,  Investments,  Financial Literacy,  Politics,  Law and Legal Matters,  Health Policy,  Diseases and Conditions,  Mental Health,  Healthy Living,  Fitness,  Science,  Technology,  Tech,  Medical Innovation and Technology,  Business Analysis,  Trends and Forecasts,  Markets,  Social Issues